ALNY Latest Headlines

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Arrowhead Pharmaceuticals (ARWR), OnKure Therapeutics (OKUR) and Alnylam Pharma (ALNY)

at www.tipranks.com (Wed, 5-Aug 9:00 AM)

AI-driven tech melt-up fuels $3.5T Nasdaq 100 surge in four days

at seekingalpha.com (Wed, 5-Aug 6:54 AM)

H.C. Wainwright Sticks to Its Buy Rating for Alnylam Pharma (ALNY)

at www.tipranks.com (Tue, 4-Aug 11:28 AM)

Truist Financial Releases a Buy Rating on Alnylam Pharma (ALNY)

at www.tipranks.com (Tue, 4-Aug 9:49 AM)

Alnylam Cuts 2026 Guidance by $200 Million Amid Fraud Investigation—How Will Investors Respond?

Market Chameleon (Mon, 3-Aug 11:45 AM)

Nasdaq pops 2% as risk appetite roars back

at seekingalpha.com (Mon, 3-Aug 2:20 PM)

Microsoft, Amazon among Nasdaq's weekly gainers after bumper earnings

at seekingalpha.com (Fri, 31-Jul 4:22 PM)

Jefferies Sticks to Their Hold Rating for Alnylam Pharma (ALNY)

at www.tipranks.com (Fri, 31-Jul 11:46 AM)

Analysts Have Conflicting Sentiments on These Healthcare Companies: Alnylam Pharma (ALNY), Ultragenyx Pharmaceutical (RARE) and Bausch Health Companies (BHC)

at www.tipranks.com (Fri, 31-Jul 9:10 AM)

RBC Capital Sticks to Their Buy Rating for Alnylam Pharma (ALNY)

at www.tipranks.com (Fri, 31-Jul 8:52 AM)

Analysts Conflicted on These Healthcare Names: Karyopharm Therapeutics (KPTI), Baxter International (BAX) and Alnylam Pharma (ALNY)

at www.tipranks.com (Fri, 31-Jul 8:00 AM)

Alnylam Pharma (ALNY) Receives a Hold from Wells Fargo

at www.tipranks.com (Fri, 31-Jul 7:46 AM)

Alnylam: Buy Rating Reiterated as Long-Term ATTR-CM Opportunity and Amvuttra Leadership Offset Guidance Cuts and Price Target Reduction to $346

at www.tipranks.com (Fri, 31-Jul 5:38 AM)

Alnylam Pharmaceuticals Delivers Record TTR Growth as Strategic Pipeline Advancements Signal Long-Term Value

Market Chameleon (Thu, 30-Jul 8:26 AM)